Skip to content

Effect of enteral nutrition on the prognosis of patients with lung cancer or breast cancer treated with internal medicine: a multicenter retrospective real-world study

Effect of enteral nutrition on the prognosis of patients with lung cancer or breast cancer treated with internal medicine: a multicenter retrospective real-world study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070143
Enrollment
Unknown
Registered
2023-04-03
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer,breast cancer

Interventions

Enteral nutrition therapy group:N/A
control group:N/A

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ?Adult patients with unresectable locally advanced or metastatic lung cancer or breast cancer confirmed by histopathological and/or cytological examination; ?AJCC stage of III or IV; ?Confirmed with at least one measurable lesion by CT or MRI according to RECIST 1.1 criteria for assessing the objective efficacy of tumor treatment; ?Assessed by NRS2002 The presence of nutritional risk or PG-SGA assessment of malnutrition; ? no serious important organ comorbidities; ? complete and reliable clinical history information

Exclusion criteria

Exclusion criteria: ?Patients with double or multiple primary malignancies; ?Patients without pathological confirmation; ?Patients with severe cardiac, hepatic or renal dysfunction or other life-threatening comorbidities; ?Patients with incomplete clinical data

Design outcomes

Primary

MeasureTime frame
Overall Survival;Progression-free Surviva;survival rate;

Secondary

MeasureTime frame
Objective Response Rate;Disease Control Rate;body mass;body mass index;total protein;prealbumin;albumin;adverse reaction rate;Severity of adverse reactions;

Countries

China

Contacts

Public ContactChen Shi

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China.

29136909@qq.com15807138405

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026